Krystal Biotech develops and makes gene therapies, including VYJUVEK, a topical treatment for a rare inherited skin disease. It last closed at $308.89 on Nov 20, down 2.19% on the day. The next earnings report for KRYS is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, KRYS reported EPS of $2.05 on revenue of $127.3M, with revenue up 30.2% from a year ago. Over its last 8 reports the stock moved an average of 7.4% the session after earnings. Over the last 12 months KRYS insiders bought $0 of stock on the open market and sold $105.3M, according to SEC Form 4 filings.
AI Auto Pilots
Is KRYS in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold KRYS.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on KRYSStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
KRYS · as of the Nov 20 close · updated each morning
Turning down
The stock is 0% below its 20 day and 4% below its 50 day average. It is sitting right on its 200 day average, a level many traders watch. Momentum is improving (RSI 47). The nearest support is the Pivot S1 at $304.32, and the nearest resistance the 20 day average at $309.56.
Short trendBearish
Long trendNeutral
MomentumImproving
StretchNormal
VolatilityNormal, 3.7%/day
Key levels
$382.5452 week high+23.8%
$335.11100 day average+8.5%
$322.4950 day average+4.4%
$317.37Pivot R1+2.7%
$312.79Pivot+1.3%
$311.05Swing high (Nov 11)+0.7%
$310.50200 day average+0.5%
$309.5620 day average+0.2%
$308.89Last close
$304.32Pivot S1−1.5%
$297.52Swing low (Nov 9)−3.7%
$203.1752 week low−34.2%
Indicators
RSI (14)
47.27
Middle of its range
Neutral
MACD
-4.22
Above its signal line
Bullish
Stochastic
68.6
Middle of its range
Neutral
ADX (14)
16.8
No clear trend
Williams %R
-45.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
35.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.7%
Change over 10 sessions
Bullish
ATR (14)
$11.42
Typical daily range, 3.7% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend
Short trendBearish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 8.4%/day
Key levels
$382.5452 week high+23.8%
$335.11100 day average+8.5%
$322.4950 day average+4.4%
$317.37Pivot R1+2.7%
$312.79Pivot+1.3%
$311.05Swing high (Nov 11)+0.7%
$310.50200 day average+0.5%
$309.5620 day average+0.2%
$308.89Last close
$304.32Pivot S1−1.5%
$297.52Swing low (Nov 9)−3.7%
$203.1752 week low−34.2%
Indicators
RSI (14)
46.97
Middle of its range
Neutral
MACD
1.82
Below its signal line
Bearish
Stochastic
25.7
Middle of its range
Neutral
ADX (14)
19.5
No clear trend
Williams %R
-70.1
Oversold below −80, overbought above −20
Neutral
CCI (20)
-111.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−11.0%
Change over 10 sessions
Bearish
ATR (14)
$25.81
Typical daily range, 8.4% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for KRYS
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how KRYS did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow KRYS usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for KRYSHow many large options trades hit KRYS, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in KRYS in the last 90 days.
From SEC Form 4 filings by KRYS's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KRYS is in one of them and how their past KRYS trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Krystal Biotech
Krystal Biotech is a biotechnology company based in Pittsburgh, Pennsylvania, that develops and manufactures gene therapies. Its platform uses an engineered herpes simplex virus to deliver therapeutic genes to target cells. Its approved product, VYJUVEK, is applied directly to the skin to treat dystrophic epidermolysis bullosa, a rare inherited skin disease, and is sold in the United States, Europe and Japan. The company also has clinical stage candidates for other rare diseases.